[Side effects of cytostatic therapy in childhood].
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D003609:Dactinomycin / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D008297:Male; D008353:Mannitol / Q000009:adverse effects / Q000031:analogs & derivatives; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects; D011344:Procarbazine / Q000009:adverse effects; D013997:Time Factors; D014228:Triaziquone / Q000009:adverse effects; D014747:Vinblastine / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D003561:Cytarabine; D003609:Dactinomycin; D011344:Procarbazine; D008353:Mannitol; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D014228:Triaziquone; D002066:Busulfan; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin
Uber Nebenwirkungen bei der Behandlung mit Zytostatika im Kindesalter